Chest Pain  >>  eleclazine (GS-6615)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
eleclazine (GS-6615) / Gilead
NCT02377336: GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

Withdrawn
2
0
Canada, Europe, RoW
GS-6615, Placebo
Gilead Sciences
Ischemic Heart Disease
08/16
08/16

Download Options